| Developers: | N.F. Gamalei National Research Center for Epidemiology and Microbiology |
| Date of the premiere of the system: | March 2021 g |
| Branches: | Pharmaceuticals, medicine, healthcare |
Content |
2021
Putin tested a nasal coronavirus vaccine after being vaccinated with Sputnik Light
Russian President Vladimir Putin tested a nasal vaccine for coronavirus after being vaccinated by Satellite Light. The head of state announced this on November 24, 2021 at a meeting with members of the Government of the Russian Federation.
 | Exactly six months [after vaccination], my protective credits dropped, and experts recommended a revaccination procedure, which I did a few days ago... At first he did it in the form of an injection, and the day after talking with Denis Yuryevich [the deputy head of the Gamalei center for scientific work Denis Logunov] he himself, by the way, did me the second part of this procedure, namely this nasal powder, "the president said. |  |
He explained that the powder preparation is taken in the same way as nasal spray.
| | It's just the same syringe, only instead of the liquid substance he [Logunov] picked up powder, asked to breathe deep into the score three, shook on the one hand, on the other hand, "Putin explained. | |
The President of Russia clarified that after the procedure he did not have any negative feelings, and on November 24 he was already engaged in sports.
Vladimir Putin on November 21, 2021 said that he was ready to participate in the trial of the vaccine for COVID-19 a nose spray - such an experiment is conducted by the Gamalei Center. Logunov answered positively:
| | Putin will be able to volunteer. | |
The head of the Hamalei Center, Alexander Ginzburg, previously said that the nasal vaccine is the second component of Sputnik V, created for spraying into the nose. In October, the Ministry of Health allowed testing the nasal form of the vaccine on volunteers during the second phase of trials of the new form of the drug. The research will last until December 2023, 500 volunteers will take part in them.[1]
Gamalea Center: Sputnik V and revaccination with a nasal drug will protect 100% from coronavirus
At the end of October 2021, the Gamalei National Research Center for Epidemiology and Microbiology announced that the use of Sputnik V and subsequent revaccination with a nasal drug would provide 100% protection against not only the severe course of coronavirus (COVID-19) infection, but also against infection with this virus in principle. More details here.
Start of clinical trials of internasal form of Satellite V vaccine
On March 22, 2021, the N.F. Gamalei National Research Center for Epidemiology and Microbiology FSBI "NITSEM named after N.F. Gamalei" Ministry of Health of Russia announced the start of clinical trials of the coronavirus vaccine "" COVID-19 in the Satellite V form of nose drops.
| | This is certainly a very gentle and convenient form of vaccination of children, especially young children... I think that this year we will start and finish the internasal clinic, "said Alexander Ginzburg, director of the center, at a meeting with Russian President Vladimir Putin on vaccination against coronavirus on March 22, 2021. | |
As the scientist noted, children for vaccination should be divided into several age groups.
| | It is necessary to start from the age, of course, 17-12 or 13 years. The next group will probably be up to eight years. Then eight, and then I find it difficult to predict this, probably three or four years, "explained Ginzburg. | |
He also suggested that further could also lower the age threshold for vaccination. Ginzburg noted that the nasal form of the vaccine is devoid of side effects.
By March 22, 2021, the Gamalei Center is preparing documents for the study of Sputnik V on children.
Ginzburg noted that children are also infected with coronavirus and it is now unknown what distant consequences after infection they will experience. Vaccination of children is a problem that has already faced the world community, he said.
In early February 2021, the Minister of Industry and Trade Denis Manturov announced that research on the coronavirus drug in the form of nasal drops will begin in April. At the same time, the mayor Moscow Sergey Sobyanin said that this type of Sputnik V will not replace full-fledged vaccination, but will be useful as an additional form of protection.[2]
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |